Last updated: February 19, 2024
Sponsor: University of Oklahoma
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dysrhythmia
Chest Pain
Arrhythmia
Treatment
Parasym
Clinical Study ID
NCT04682704
12708
Ages 21-90 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male and female patients older than 21 year old
- Healthy volunteers free from diagnosis of AF, heart failure, coronary artery diseaseor diseases that affect the autonomic nervous system.
- Patients with Paroxysmal Atrial Fibrillation
- Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
Exclusion
Exclusion Criteria:
- Recent (<6 months) stroke
- Recent (<6 months) myocardial infarction
- Heart failure (NYHA class III or IV)
- Left ventricular ejection fraction <50%
- Recurrent vaso-vagal syncopal episodes
- Unilateral or bilateral vagotomy
- Pregnancy or breast feeding
- Uncontrolled diabetes or hypertension
- Inability or unwillingness to understand and/or sign informed consent
- Any serious disease that affects autonomic nervous system function
- Any medications that affect autonomic nervous system function
Study Design
Total Participants: 90
Treatment Group(s): 1
Primary Treatment: Parasym
Phase:
Study Start date:
November 30, 2021
Estimated Completion Date:
February 28, 2025
Connect with a study center
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.